42358
双十八烷基胺
≥99.0% (NT)
别名:
DODA, 二硬脂酸胺
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
[CH3(CH2)17]2NH
化学文摘社编号:
分子量:
521.99
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
204-020-2
Beilstein/REAXYS Number:
1801688
MDL number:
产品名称
双十八烷基胺, ≥99.0% (NT)
InChI key
HKUFIYBZNQSHQS-UHFFFAOYSA-N
InChI
1S/C36H75N/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h37H,3-36H2,1-2H3
SMILES string
CCCCCCCCCCCCCCCCCCNCCCCCCCCCCCCCCCCCC
assay
≥99.0% (NT)
mp
71-73 °C
solubility
water: soluble(lit.)
functional group
amine
Quality Level
正在寻找类似产品? 访问 产品对比指南
Application
二十八烷基胺（DODA）是用于以下合成的合适试剂：
- 二十八烷基胺-BCN（双环[6.1.0]壬炔）缀合物。
- 双乙基去甲精胺（BSP）的脂质衍生物。
- 功能性VP（N-乙烯基吡咯烷酮）聚合物。
- 作为与二琥珀酰亚胺基 4,4'-偶氮双（4-氰基戊酸酯）反应合成 4,4'-偶氮双（4-氰基- N,N -双十八烷基）戊酰胺 (DODA-501) 的反应物。
- 作为合成双十八烷基七肽的试剂。
- 作为金纳米粒子 (AuNPs) 在非极性溶剂中的相转移和稳定剂。
General description
二十八烷基胺（DODA）是一种仲胺，是一种脂肪胺衍生物。 已经评估了其生物降解潜力。观察发现，在水性介质中，DODA自身组织成板状结构。分析了其部分电荷分布与其构象的关系。 已确定二十八烷基胺Langmuir单层的相图，研究表明其在pH 3.9以上不会形成单层。DODA已用于形成脂质体、阳离子脂质或脂质螯合剂。
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
target_organs
Respiratory system
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Cong-Anh-Khanh Le et al.
International journal of biological macromolecules, 119, 555-564 (2018-07-31)
The crystallization of amylose from dilute solutions in the presence of a series of linear saturated fatty acids (C3 to C20) was investigated by varying the fatty acid concentration, crystallization temperature and solvent composition (DMSO:water in various ratios). The morphology
Biomimetic lipoglycopolymer membranes: photochemical surface attachment of supramolecular architectures with defined orientation.
Stefan M Schiller et al.
Angewandte Chemie (International ed. in English), 48(37), 6896-6899 (2009-08-19)
Stefan Bleher et al.
Small (Weinheim an der Bergstrasse, Germany), 15(50), e1904716-e1904716 (2019-11-14)
Circulation lifetime is a crucial parameter for a successful therapy with nanoparticles. Reduction and alteration of opsonization profiles by surface modification of nanoparticles is the main strategy to achieve this objective. In clinical settings, PEGylation is the most relevant strategy
Self-assembling nanoscaled drug delivery systems composed of amphiphilic poly-N-vinylpyrrolidones.
Kuskov AN, et al.
Journal of Non-Crystalline Solids, 353(41), 3969-3975 (2007)
K Ohno et al.
Bioconjugate chemistry, 6(4), 361-366 (1995-07-01)
A galactose-containing monomer (2-(methacryloyloxy)ethyl beta-D-galactopyranoside, MEGal) was polymerized by using a lipophilic radical initiator. The amphiphile obtained formed a liposome by mixing with bis(trans,trans-2,4-dioctadecadienoyl)phosphatidylcholine (DDPC), and the liposome obtained was physically stabilized by the polymerization of DDPC by UV irradiation.
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持